Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.

BACKGROUND: Group B streptococcus is the leading cause of infection in infants. Currently, intrapartum antibiotic prophylaxis is the major strategy to prevent invasive group B streptococcus disease. However, intrapartum antibiotic prophylaxis does not prevent maternal sepsis, premature births, still...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Health Technol Assess
Glavni autori: Carreras-Abad, Clara, Cochet, Madeleine, Hall, Tom, Ramkhelawon, Laxmee, Khalil, Asma, Peregrine, Elisabeth, Vinayakarao, Latha, Sivarajan, Sharmila, Hamid, Rosol, Planche, Tim, Sheridan, Elizabeth, Winchester, Stephen, Plumb, Jane, Djennad, Abdelmajid, Andrews, Nick, Le Doare, Kirsty, Heath, Paul
Format: Artigo
Jezik:Inglês
Izdano: NIHR Journals Library 2019
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6936166/
https://ncbi.nlm.nih.gov/pubmed/31855555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta23670
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items